Last reviewed · How we verify

Prevent pregnancy — Treatment Landscape & Competitive Intelligence

Prevent pregnancy (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevent pregnancy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Nextstellis ESTETROL Mayne Pharma Estrogen Estrogen receptor 2021-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Mayne Pharma · 1 drug in Prevent pregnancy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevent pregnancy:

Cite this brief

Drug Landscape (2026). Prevent pregnancy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevent-pregnancy. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing